Cargando…

Recurrent chronic thromboembolic disease despite optimal anticoagulation in setting of recent COVID-19 infection

We present a case of a 38-year-old man with a history of chronic thromboembolic pulmonary hypertension on therapeutic anticoagulation and recent hospitalisation for COVID-19 disease who was hospitalised for recurrent acute pulmonary embolism despite therapeutic anticoagulation with warfarin (Interna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terrigno, Vittorio Romeo, Ricketti, Daniel Anthony, Patel, Pranav, Roy, Satyajeet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844927/ https://www.ncbi.nlm.nih.gov/pubmed/33509878 http://dx.doi.org/10.1136/bcr-2020-238733

Ejemplares similares

Association of Elevated Levels of Inflammatory Marker High-Sensitivity C-Reactive Protein and Hypertension
por: Bisaria, Sharmila, et al.
Publicado: (2020)

Recurrent Venous Thromboembolism in a Patient with Klippel-Trenaunay Syndrome Despite Adequate Anticoagulation with Warfarin
por: Asnake, Zekarias T, et al.
Publicado: (2020)

High-Sensitivity Troponin for Suspected Acute Coronary Syndrome in Patients With Chronic Kidney Disease Versus Patients Without Chronic Kidney Disease
por: Clemons, David, et al.
Publicado: (2021)

Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
por: Miesbach, W., et al.
Publicado: (2004)

Anticoagulation failure in pulmonary thromboembolism in COVID-19 pneumonia despite prolonged anticoagulation: A case series
por: Sapkota, Prakash, et al.
Publicado: (2022)

A Case of COVID-19 Complicated by Venous Thromboembolism Despite Being on Prophylactic Anticoagulation
por: Rout, Amit, et al.
Publicado: (2020)

Optimal duration of anticoagulation in patients with venous thromboembolism
por: Prandoni, Paolo, et al.
Publicado: (2011)

Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy
por: Finks, Shannon W., et al.
Publicado: (2016)

Acute on Chronic Venous Thromboembolism on Therapeutic Anticoagulation
por: Bassi, Byron, et al.
Publicado: (2013)

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017)

Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension
por: Zhu, Yong-Jian, et al.
Publicado: (2021)

Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy
por: Jeong, Ina, et al.
Publicado: (2022)

Dual Anticoagulation in Recurrent Thromboembolic Events with Failure of Monotherapy: A Novel Approach
por: Chintalacheruvu, Lakshmi Manogna, et al.
Publicado: (2017)

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
por: de Winter, Maria A, et al.
Publicado: (2023)

P1641: RECURRENT VENOUS THROMBOEMBOLISMS AND ANTICOAGULATION COMPLICATIONS; A PROSPECTIVE STUDY.
por: Nasibov, Teymur, et al.
Publicado: (2023)

Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension
por: Gavilanes-Oleas, Francisca Alexandra, et al.
Publicado: (2018)

Real-life data of direct anticoagulant use, bleeding risk and venous thromboembolism recurrence in chronic thromboembolic pulmonary hypertension patients: an observational retrospective study
por: Sena, Sert, et al.
Publicado: (2020)

Recurrent thromboembolism, bleeding, and mortality in Asian patients with venous thromboembolism receiving different oral anticoagulants: A nationwide analysis
por: Lee, Mei-Chuan, et al.
Publicado: (2022)

Splinters in the fingernails, heart and brain: thromboembolic complications of non-bacterial thrombotic endocarditis despite treatment with a direct-acting oral anticoagulant
por: Wang, Louis W, et al.
Publicado: (2022)

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis
por: Lopes, Luciane Cruz, et al.
Publicado: (2014)

Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism
por: Carney, Brian J., et al.
Publicado: (2020)

New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)

New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016)

Thromboembolism and anticoagulation after Fontan surgery
por: Viswanathan, Sangeetha
Publicado: (2016)

Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)

Venous Thromboembolism While on Anticoagulation With Apixaban
por: Mazahreh, Farah, et al.
Publicado: (2021)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Arterial thromboembolic complications in COVID‐19 in low‐risk patients despite prophylaxis
por: Griffin, Daniel O., et al.
Publicado: (2020)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Venous thromboembolism in the setting of IVC calcification managed with pharmacomechanical thrombectomy and anticoagulation: A case report
por: Belay, Abel A, et al.
Publicado: (2021)

Clinical characteristics and symptom duration among outpatients with COVID-19
por: Lane, Alexandra, et al.
Publicado: (2022)

New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
por: McRae, Simon J, et al.
Publicado: (2005)

Pharmacology of anticoagulants used in the treatment of venous thromboembolism
por: Nutescu, Edith A., et al.
Publicado: (2016)

New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
por: Kim, Joo Hee, et al.
Publicado: (2017)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Anticoagulation in Neonatal ECMO: An Enigma Despite a Lot of Effort!
por: Cashen, Katherine, et al.
Publicado: (2019)

COVID-19-associated ischaemic stroke despite use of anticoagulation
por: Sharma, Shyam, et al.
Publicado: (2021)

Half-Dose Anticoagulation for Venous Thromboembolism and Phlegmasia Cerulea Dolens in a Patient With Recurrent Subdural Hematoma
por: Hu, Junfei, et al.
Publicado: (2021)

Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients
por: Wang, Julie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0klv5uklclpv33ak9vcn8vppgp